These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 11785667

  • 21. Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model.
    Bestas B, Moreno PM, Blomberg KE, Mohammad DK, Saleh AF, Sutlu T, Nordin JZ, Guterstam P, Gustafsson MO, Kharazi S, Piątosa B, Roberts TC, Behlke MA, Wood MJ, Gait MJ, Lundin KE, El Andaloussi S, Månsson R, Berglöf A, Wengel J, Smith CI.
    J Clin Invest; 2014 Sep; 124(9):4067-81. PubMed ID: 25105368
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Role of Bruton's tyrosine kinase in immunodeficiency.
    Tsukada S, Rawlings DJ, Witte ON.
    Curr Opin Immunol; 1994 Aug; 6(4):623-30. PubMed ID: 7946052
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
    Mizuno T, Rothstein TL.
    J Immunol; 2003 Mar 15; 170(6):2806-10. PubMed ID: 12626529
    [Abstract] [Full Text] [Related]

  • 26. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
    Hashimoto S, Tsukada S, Matsushita M, Miyawaki T, Niida Y, Yachie A, Kobayashi S, Iwata T, Hayakawa H, Matsuoka H, Tsuge I, Yamadori T, Kunikata T, Arai S, Yoshizaki K, Taniguchi N, Kishimoto T.
    Blood; 1996 Jul 15; 88(2):561-73. PubMed ID: 8695804
    [Abstract] [Full Text] [Related]

  • 27. Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase.
    Novina CD, Kumar S, Bajpai U, Cheriyath V, Zhang K, Pillai S, Wortis HH, Roy AL.
    Mol Cell Biol; 1999 Jul 15; 19(7):5014-24. PubMed ID: 10373551
    [Abstract] [Full Text] [Related]

  • 28. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.
    Dingjan GM, Maas A, Nawijn MC, Smit L, Voerman JS, Grosveld F, Hendriks RW.
    EMBO J; 1998 Sep 15; 17(18):5309-20. PubMed ID: 9736610
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain.
    Li T, Tsukada S, Satterthwaite A, Havlik MH, Park H, Takatsu K, Witte ON.
    Immunity; 1995 May 15; 2(5):451-60. PubMed ID: 7538439
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition.
    Kouro T, Nagata K, Takaki S, Nisitani S, Hirano M, Wahl MI, Witte ON, Karasuyama H, Takatsu K.
    Int Immunol; 2001 Apr 15; 13(4):485-93. PubMed ID: 11282988
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.